Charles River Laboratories International, Inc. (CRL) Shareholders & Insider Trades
Charles River Laboratories International shareholders at a glance
The largest holder of Charles River Laboratories International stock is Fidelity Management & Research Co. LLC, with 4.2 million shares (8.88% of the company), worth about $1.22 billion as of September 25, 2026. The 10 largest holders together own 52.3%.
In Q2 2026, 589 institutional holdings reports listed shares worth $13.40 billion.
Insiders reported 63 transactions in the last two years: 8 sales worth $2.73 million and 3 purchases. The newest one on file is from May 12, 2026 (Andrews Nancy C, Director).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through May 12, 2026.
Charles River Laboratories International, Inc.
Shareholders Summary
2026Q2
Ownership by Type
Geographic Distribution
Largest Charles River Laboratories International shareholders
| Holder | Shares | % of company | Value |
|---|---|---|---|
| Fidelity Management & Research Co. LLC | 4.2 million | 8.88% | $1.2B |
| BlackRock Advisors LLC | 3.3 million | 6.92% | $953.0M |
| Vanguard Capital Management LLC | 3.1 million | 6.60% | $908.0M |
| Invesco Advisers, Inc. | 3.0 million | 6.25% | $860.0M |
| Harris Associates LP | 2.2 million | 4.70% | $646.0M |
| Vanguard Portfolio Management LLC | 2.2 million | 4.63% | $637.0M |
| Allspring Global Investments LLC | 1.9 million | 3.99% | $549.0M |
| State Street Corporation | 1.9 million | 3.90% | $537.0M |
| DFA Australia Ltd. | 1.6 million | 3.27% | $451.0M |
| Ariel Investments LLC | 1.5 million | 3.15% | $434.0M |
As of September 25, 2026.
Charles River Laboratories International institutional holdings by quarter
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 589 | – | $13.4B |
| Q1 2026 | 581 | – | $10.0B |
| Q4 2025 | 606 | – | $10.6B |
| Q3 2025 | 582 | – | $8.0B |
| Q2 2025 | 554 | 51.8 million | $7.9B |
| Q1 2025 | 589 | 53.4 million | $8.0B |
| Q4 2024 | 668 | 55.0 million | $10.0B |
| Q3 2024 | 659 | 52.8 million | $10.4B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
Charles River Laboratories International insider trades
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Andrews Nancy C | May 12, 2026 | Director | Stock Gift at price 0.00 per share. | – |
| Kemps-Polanco Reshema | May 8, 2026 | Director | Stock Award(Grant) at price 177.62 per share. | $350,444 |
| Foster James C | May 8, 2026 | Director | Stock Award(Grant) at price 177.62 per share. | $330,373 |
| Graves Paul W | May 8, 2026 | Director | Stock Award(Grant) at price 177.62 per share. | $255,418 |
| Andrews Nancy C | May 8, 2026 | Director | Stock Award(Grant) at price 177.62 per share. | $255,418 |
| Llado George Sr. | May 8, 2026 | Director | Stock Award(Grant) at price 177.62 per share. | $335,347 |
| Barg Steven | May 8, 2026 | Director | Stock Award(Grant) at price 177.62 per share. | $255,418 |
| Mackay Martin | May 8, 2026 | Director | Stock Award(Grant) at price 177.62 per share. | $505,329 |
| Thompson Craig B | May 8, 2026 | Director | Stock Award(Grant) at price 177.62 per share. | $255,418 |
| Wilson Virginia M | May 8, 2026 | Director | Stock Award(Grant) at price 177.62 per share. | $255,418 |
| Enyedy Mark J | May 8, 2026 | Director | Stock Award(Grant) at price 177.62 per share. | $255,418 |
| Ceesay Abraham N | May 8, 2026 | Director | Stock Award(Grant) at price 177.62 per share. | $255,418 |
Newest 12 of 63 insider transactions in the last two years.
Questions and answers
Who owns the most Charles River Laboratories International stock?
Fidelity Management & Research Co. LLC, with 8.88% of the company (as of September 25, 2026). Next: BlackRock Advisors LLC (6.92%) and Vanguard Capital Management LLC (6.60%).
How many institutions own Charles River Laboratories International stock?
589 institutional holdings reports listed Charles River Laboratories International shares in Q2 2026 worth $13.40 billion.
Are Charles River Laboratories International insiders buying or selling the stock?
In the last two years insiders reported 8 sales and 3 purchases (63 transactions in all); the newest on file is from May 12, 2026.
